Celsion CorpAdd to My Watchlist

CLSN:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 0.23
    Last
  • 0.01  -3.69%
    Today's Change
  • 0.24
    Previous Close
  • Today
     
    0.19
    1.60
    52 Week Low - High
4:30 pm ET 5/26/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding57 million
Market Cap$13 million
Return on Equity ttm-200.77%
Last DividendCLSN:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.719
EPS: Year Est. 12/17 ttm-0.330
 
EPS: Quarterly Actual 3/17 -0.12
EPS: Quarterly Est. 6/17 -0.10
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate17.48
Company Description
Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.
Revenue$500,000
Net Income$-22 million
Total Assets$31 million
Employees19
Web Sitewww.celsion.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!